Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ergothioneine.
Ergothioneine is a unique sulfur-containing amino acid derivative that functions as a potent cytoprotective antioxidant and mitochondrial protector, utilizing the specific SLC22A4 (OCTN1) transporter for high-affinity cellular uptake and tissue distribution.
21750
226.19 g/mol
0.7
1-ethyl-1-[(5-nitrofuran-2-yl)methylideneamino]urea
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ergothioneine across standard consumer modalities.
The hygroscopic nature of ergothioneine requires moisture-resistant HPMC capsules and desiccants to prevent clumping and maintain long-term chemical stability.
High processing temperatures during the pectin gelation phase may risk thermal degradation of the thiol group, necessitating precise temperature control or post-cook addition.
The relatively low therapeutic dosage of ergothioneine is suitable for thin-film matrices, though its inherent sulfurous odor requires advanced flavor masking and inclusion complexation.
Ready to launch a product featuring Ergothioneine? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Ergothioneine extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Ergothioneine payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation